TAVR benefits high-risk patients with moderate aortic stenosis

Coverage, in order

1. 8d ago
   
   first Medical Xpress indie

   Earlier valve replacement benefits some patients with moderate aortic stenosis

   Patients with moderate aortic stenosis, a narrowing of the heart's aortic valve, may benefit from undergoing transcatheter aortic valve replacement (TAVR) before the disease becomes severe, according to findings from a clinical trial co-led by Cedars-Sinai investigators.

2. 8d ago
   
   Healio indie observational

   TAVR benefits high-risk patients with moderate aortic stenosis

   In patients with moderate aortic stenosis with at least one at-risk feature, transcatheter aortic valve replacement was linked to reduced risk for death or a heart failure event at 2 years compared with clinical surveillance, data show. “This is going to be a turning point in the way that we see…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.